The intervention being tested is Avacopan, an oral medication intended to provide long-term treatment for ANCA-associated vasculitis. The study includes three groups: one receiving Avacopan with ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals recently ...

Patients with AAV and kidney involvement who take SGLT-2 inhibitors may have a reduced risk for ESRD and kidney transplant ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a Phase 3 ...

I recently had the privilege of speaking at the Advances in Rheumatology and Technologies Symposium (ARTS), held in Chicago ...

Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...

Learn more about whether Biogen Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

SLE patients with lupus nephritis (LN) surpassing a 3-month post-treatment time point (n=2) achieved complete renal response (CRR) at 6 months; first patient continues in drug-free Definition of ...

RA-ILD has worse outcomes than RA and is most likely in those with extra-articular RA manifestations and in those who are older, male, and non-White.

As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were ...

Yes, that’s correct. Kidney disease often progresses for years without symptoms until it reaches an advanced stage when kidneys may have lost up to 90% of their function. The only way to detect it ...

Objectives To investigate whether systemic lupus erythematosus (SLE) increases the risk of cataract development and to ...